Logo Beilstein Institut

Formal total syntheses of classic natural product target molecules via palladium-catalyzed enantioselective alkylation

  1. ,
  2. ,
  3. ,
  4. ,
  5. ,
  6. ,
  7. ,
  8. ,
  9. ,
  10. ,
  11. and
Warren and Katharine Schlinger Laboratory of Chemistry and Chemical Engineering, Division of Chemistry and Chemical Engineering, California Institute of Technology, 1200 E. California Boulevard, Pasadena, CA, USA
  1. Corresponding author email
Associate Editor: S. Bräse
Beilstein J. Org. Chem. 2014, 10, 2501–2512. https://doi.org/10.3762/bjoc.10.261
Received 11 Aug 2014, Accepted 09 Oct 2014, Published 28 Oct 2014
Full Research Paper
cc by logo
PDF
Album
Supp Info
Cite

Abstract

Pd-catalyzed enantioselective alkylation in conjunction with further synthetic elaboration enables the formal total syntheses of a number of “classic” natural product target molecules. This publication highlights recent methods for setting quaternary and tetrasubstituted tertiary carbon stereocenters to address the synthetic hurdles encountered over many decades across multiple compound classes spanning carbohydrate derivatives, terpenes, and alkaloids. These enantioselective methods will impact both academic and industrial settings, where the synthesis of stereogenic quaternary carbons is a continuing challenge.

Keywords: enantioselective alkylation; natural products; palladium

Introduction

Catalytic enantioselective allylic alkylation has emerged as a powerful method for the construction of building blocks bearing quaternary carbon and fully substituted tertiary centers [1,2]. A recent addition developed by our laboratory is the allylic alkylation of nonstabilized enolate precursors to form α-quaternary carbonyl compounds (Scheme 1) [3]. Once the key stereocenter is set by this chemistry, further elaboration allows access to many bioactive small molecules. In our lab alone, this palladium-catalyzed alkylation has enabled the enantioselective total syntheses of dichroanone [4], elatol [5], cyanthiwigins [6-8], carissone [9], cassiol [10], chamigrenes [11], and liphagal [12]. Other labs have also utilized our method in natural product total synthesis [13,14]. Often, it is the case that a new technology that allows the synthesis of building blocks will open up new avenues to complex structures of long standing interest [15,16]. Herein we detail the application of this asymmetric chemistry in formal total syntheses of “classic” natural product targets across a range of compound families by strategic selection of allylic alkylation substrates and subsequent product transformations.

[1860-5397-10-261-i1]

Scheme 1: Three classes of Pd-catalyzed enantioselective allylic alkylations.

Results and Discussion

A) Thujopsene

The Japanese hiba tree, Thujopsis dolabrata has been used for centuries as decoration and within traditional architecture [17]. The plant is a member of the order Cupressaceae, and its fragrant wood oil contains numerous sesquiterpenes including mayurone (8) [18,19], widdrol (9) [20], and (−)-thujopsene (10) (Figure 1) [21,22]. The wood oil is a potent dust mite deterrent; thus, in addition to its ornamental value, the hiba tree also provides and environmentally benign means of pest control [23,24].

[1860-5397-10-261-1]

Figure 1: Selected natural products from Thujopsis dolabrata.

(−)-Thujopsene (10) has attractive features to the synthetic chemist. Its tricyclo[5.4.0.01,3]undecane skeleton contains three contiguous all-carbon quaternary centers, two of which are stereogenic. Being a hydrocarbon, (−)-thujopsene (10) has few natural handles for retrosynthetic analysis. Inspired by the complexity of this relatively small natural product, several total syntheses of racemic 10 have been reported [25-29] along with at least two enantioselective routes [30-32].

One enantiospecific total synthesis of (+)-thujopsene (10) by Srikrishna and Anebouselvy began with (R)-carvone (11) (Scheme 2) [33]. During the total synthesis, the authors prepared carboxylic acid (+)-12 over a 14-step sequence. We planned to intercept the antipode of (+)-12 using the palladium-catalyzed enantioselective alkylation chemistry described above.

[1860-5397-10-261-i2]

Scheme 2: Srikrishna and Anebouselvy’s approach to (+)-thujopsene.

We commenced a formal total synthesis of (−)-thujopsene (10) with the goal of improved efficiency compared to the Srikrishna/Anebouselvy route and to use enantioselective palladium catalysis to install the initial stereocenters (Scheme 3). Treatment of 16 with LiHMDS in THF, followed by allyl chloroformate, furnished the known carbonate 17 in high yield [34]. This substrate smoothly undergoes palladium-catalyzed enantioselective decarboxylative allylation in the presence of (S)-t-Bu-PHOX (5), giving allyl ketone (−)-18 in 94% yield and 91% ee [34]. Treatment of the ketone (−)-18 with MeMgBr at 23 ºC provided a mixture of two diastereomeric alcohols 19A and 19B in 94% yield. Without separation, the diastereomers were rapidly carried through a three-step sequence of hydroboration/oxidation, terminal alcohol silylation, and tertiary alcohol dehydration, affording methylene cyclohexane (−)-20. Treatment of this silyl ether with Jones reagent simultaneously cleaved the silyl group and oxidized the resulting alcohol, furnishing carboxylic acid (−)-12 in 65% yield. With this enantioenriched acid in hand, the formal total synthesis of (−)-thujopsene (10) is completed in only 9 steps from trimethylcyclohexanone 16.

[1860-5397-10-261-i3]

Scheme 3: Formal total synthesis of (−)-thujopsene.

B) Quinic acid

(−)-Quinic acid (21) [35,36] serves as a useful chiral building block that has been employed in numerous syntheses [37], including our own syntheses of (+)- and (−)-dragmacidin F [38-41], and the initial commercial-scale synthesis of Tamiflu [42]. In Renaud’s formal total synthesis of (−)-quinic acid (21) [35], a key carboxylic acid 22 was accessed, intercepting Novak’s older synthesis of the natural product (Scheme 4) [36]. To begin, Renaud transformed the chiral glycolic acid ketal 23 (enantioenriched to 80% ee) to the more elaborate diene 24 via two diastereoselective alkylations. After a sequence of three reactions including removal of the pinacolone portion of the auxiliary, carboxylic acid 22 could be accessed. Novak’s synthesis applied a bromolactonization of 22 to build in the requisite syn relationship between the carboxylate group and the 3-hydroxy group, ultimately leading to quinic acid.

[1860-5397-10-261-i4]

Scheme 4: Renaud’s formal total synthesis of (−)-quinic acid.

Unlike the allylic alkylations in Scheme 1, which form all-carbon stereocenters, we envisioned a unique modification of the silyl enol ether version to access nonracemic tertiary alcohols (Scheme 5) [43]. The planned modification would involve the use of dioxanone-derived substrates instead of the prototypical cycloalkanone-derived ones. To demonstrate this new technology in the context of formal total synthesis, we chose to intercept the acid 22 in the Renaud and Novak routes to quinic acid (21). Conversion of dioxanone 25 to a cyclohexylimine enabled alkylation via a metalloenamine. On acidic work-up, imine hydrolysis furnished an alkylated dioxanone in good yield. The targeted silyl enol ether 26 was prepared by thermodynamic silylation in 66% yield [43]. Optimal conversions and enantioselectivities were achieved from triethylsilyl enol ether 26 on exposure to [Pd(dmdba)2] (5 mol %), (S)-t-BuPHOX (5, 5.5 mol %), and diallyl carbonate (1.05 equiv) at 25 °C, in PhMe with an equivalent of Bu4NPh3SiF2 (TBAT) [43]. Recognizing that enantioenriched α,ω-dienes could be transformed into cycloalkenes with a stereocenter remote to the olefin [44], chiral diene 27 was submitted to ring closing metathesis to generate 28 in 90% yield and 92% ee [43]. Cyclohexene 28 readily undergoes acetonide cleavage and periodic acid oxidation to provide carboxylic acid (S)-22 [43], completing the formal synthesis of (−)-quinic acid (21). Additionally, one could in principle also access the less commercially abundant antipode (+)-quinic acid (21) using the catalyst (R)-t-Bu-PHOX.

[1860-5397-10-261-i5]

Scheme 5: Formal total synthesis of (−)-quinic acid.

C) Dysidiolide

Dysidiolide (29, Scheme 6) was isolated from the marine sponge Dysidea etheria and found to have inhibitory activity toward protein phosphatase cdc25, with an IC50 value of 9.4 µM [45]. This enzyme is a member of the protein family responsible for dephosphorylation of cyclin-dependent kinases [46]. Thus, inhibitors of cdc25 might allow for targeted cell-cycle disruption [45]. The relative stereochemistry of dysidiolide (29) was determined via single-crystal X-ray diffraction analysis, revealing a molecule with six stereocenters, two of which are quaternary carbons [45]. Several groups have reported total syntheses of this natural product [47-53], three of which are enantioselective [54-56].

[1860-5397-10-261-i6]

Scheme 6: Danishefsky’s approach to (±)-dysidiolide.

In Danishefsky’s approach to racemic dysidiolide, the cyclohexene ring of 30 was installed via diastereoselective Diels–Alder reaction of a transient dioxolenium dienophile and chiral vinylcyclohexene 31 [48]. Triene 31 was prepared from α-quaternary ketone (±)-32 in racemic form. We anticipated the interception of (−)-32 [57] in Danishefsky’s route using enantioselective palladium-catalyzed allylic alkylation to set the quaternary stereocenter.

The formal total synthesis of (−)-dysidiolide (29) commenced with known allyl β-ketoester 4 (Scheme 7), which was converted to 2-allyl-2-methylcyclohexanone (2) in 85% yield and 88% ee [58] with a catalytic amount of [Pd2(dba)3] and (S)-t-BuPHOX (5, Scheme 1). The allyl ketone was enriched to 98% ee via recrystallization of semicarbazone 33 [59]. Using the Grubbs 2nd generation metathesis catalyst, allyl ketone (−)-2 was crossed with methyl vinyl ketone in 62% yield [34]. Reduction of enone 34 was achieved in the presence of Pd/C with H2 in EtOAc to furnish diketone 35 [34]. Chemoselective Wittig mono-olefination of 35 provided ω-enone (−)-32, spectroscopically identical to the material in Danishefsky’s racemic synthesis. This formal synthesis shows the power of the enantioselective allylic alkylation to access formerly racemic constructs as single enantiomers; Danishefsky’s synthesis is now rendered enantioselective.

[1860-5397-10-261-i7]

Scheme 7: Formal total synthesis of (−)-dysidiolide.

D) Aspidospermine

The aspidosperma alkaloids have garnered much attention as beautiful targets for the synthetic chemist. Most of the 250-plus compounds in this class share a pentacyclic core, from the clinical anticancer therapeutics vincristine and vinblastine to the simpler aspidospermidine [60]. To address the challenging synthetic features of the aspidosperma alkaloids, many clever synthetic approaches have been reported [61,62]. One popular target in this family is aspidospermine (36, Scheme 8). Although its medicinal potency is inferior to other members of the class, this alkaloid has served as a proving ground for many synthetic chemists.

[1860-5397-10-261-i8]

Scheme 8: Meyers’ approach to unnatural (+)-aspidospermine.

In 1989, Meyers reported an enantioselective synthesis of the (4aS,8aR,8S)-hydrolilolidone core 37 [63,64] present in aspidospermine (36), and thus a formal total synthesis of the alkaloid itself, intercepting Stork’s classic route [61]. One precursor described in the core synthesis is enone 38, which bears the quaternary stereocenter of the natural product. Contrasting Meyers’ approach, which employed a chiral auxiliary as part of 39, we thought a catalytic enantioselective alkylation strategy would be ideal for a formal total synthesis of natural (−)-aspidospermine (36) via the antipode of 38.

The formal synthesis began with 1,3-cyclohexanedione (40), which was converted to isobutyl vinylogous ether 41 under acid promotion (Scheme 9) [65]. The β-ketoester 42 was prepared using a two-step sequence of acylation and alkylation, then treated with the (S)-t-Bu-PHOX catalyst system (with [Pd(dmdba)2]) to generate (+)-43 in 86% ee. The challenge of installing the γ-stereocenter of the target 38 was addressed as follows: LiAlH4 treatment of (+)-43 gave exclusive 1,2-reduction. When the crude product was hydrolyzed, β-elimination gave the desired enone 38. The overall formal synthesis represents a rare example of enantioselective Stork–Danheiser chemistry [66,67].

[1860-5397-10-261-i9]

Scheme 9: Formal total synthesis of (−)-aspidospermine.

E) Rhazinilam

(−)-Rhazinilam (44) has been isolated from various plants including Rhazya strica decaisne [68], Melodinus australis [69], and Kopsia singapurensis [70]. Shortly after the first isolation, its structure was elucidated by single crystal X-ray diffraction analysis [71]. It features a tetracyclic scaffold with a nine-membered ring and an all-carbon quaternary stereocenter. This alkaloid is a microtubule-disrupting agent that displays similar cellular effects to paclitaxel [72,73]. Because of its biological activities and potential pharmaceutical use, many groups have pursued its total synthesis [74-77], including a number of enantioselective syntheses [78-82].

In 2001, Magnus reported a total synthesis of rhazinilam in racemic form (Scheme 10) [83]. In their approach, the first retrosynthetic disconnection of the amide C–N bond in the nine-membered ring led to tricyclic compound 45. The pyrrole ring of 45 was formed by intramolecular condensation of cinnamyl amide 46, which is prepared via union of quaternary piperidinone 47 and cinnamyl electrophile 48. We envisioned that our allylic alkylation of lactam enolates would furnish enantioenriched piperidinone 47, and thus a single enantiomer of rhazinilam may be prepared.

[1860-5397-10-261-i10]

Scheme 10: Magnus’ approach to (±)-rhazinilam.

The formal synthesis of (+)-rhazinilam commenced with palladium-catalyzed decarboxylative allylic alkylation of known carboxy-lactam 49 to afford benzoyl-protected piperidinone 50 in 97% yield and 99% ee (Scheme 11) [84]. Cleavage of the benzoyl group under basic conditions furnished piperidinone (+)-47 [84], which can be advanced to (+)-rhazinilam via Magnus’ route. This formal synthesis demonstrates the utility of our recently developed asymmetric lactam alkylation chemistry.

[1860-5397-10-261-i11]

Scheme 11: Formal total synthesis of (+)-rhazinilam.

F) Quebrachamine

Quebrachamine (51) is an indole alkaloid isolated from the Aspidosperma quebracho tree bark [60]. It has been found to possess adrenergic blocking activities for a variety of urogenital tissues [85]. Structurally, it features a tetracycle including an indole nucleus, a 9-membered macrocycle, and an all-carbon quaternary stereocenter. Due to its structural complexity and biological activities, quebrachamine has received considerable attention from the chemistry community. A number of total syntheses have been reported [86-88], with several examples of asymmetric syntheses [89-91].

In 2007, Amat reported an enantioselective total synthesis of quebrachamine (Scheme 12) [92]. In their planning, disconnection at the macrocycle led to amide 52, which was prepared from 3,3-disubstituted piperidine 53. The all-carbon quaternary stereocenter in 53 was installed by double alkylation of lactam 55, using an auxiliary to control the stereoselectivity. We envisioned that an alternative way of constructing this motif would again make use of our recently developed palladium-catalyzed asymmetric alkylation of lactam enolates.

[1860-5397-10-261-i12]

Scheme 12: Amat’s approach to (−)-quebrachamine.

The formal synthesis of (+)-quebrachamine commenced with benzoyl lactam 50 (Scheme 13), which was prepared in excellent yield and ee by alkylation of carboxy-lactam 49 (see Scheme 11) [84]. Oxidative cleavage of the terminal double bond and subsequent reduction with LiAlH4 afforded N-benzylpiperidine-alcohol 56 [84]. Hydrogenolysis of the N-benzyl group and re-protection with di-tert-butyl dicarbonate furnished N-boc piperidine-alcohol (+)-53 [84], thus intercepting an intermediate in Amat’s synthesis of quebrachamine.

[1860-5397-10-261-i13]

Scheme 13: Formal total synthesis of (+)-quebrachamine.

G) Vincadifformine

Vincadifformine (59) was isolated in both enantioenriched and racemic forms from the leaves and roots of Rhazya stricta in 1963 [93]. Not only is it a representative member of the Aspidosperma alkaloid family, but it also holds particular significance as a valuable precursor to pharmaceutically important vincamine, vincamone, and cavinton [94-97]. The molecule has a fused pentacyclic framework with three contiguous stereocenters, two of which are all-carbon quaternary centers. The medicinal relevance and structural complexity of vincadifformine have led to a large number of total syntheses [98-104], including several enantioselective examples [105-108].

Recently, Pandey reported a highly efficient synthesis of (+)-vincadifformine (Scheme 14) [106]. The key step in the synthesis was an iminium ion cascade reaction that formed the fused ring systems by coupling 3,3-disubstituted tetrahydropyridine 57 with indole derivative 58. The former coupling partner was derived from chiral α-quaternary lactam 60, which was constructed using a chiral auxiliary strategy. We envisioned that chiral lactam 60 could again be readily accessed by our palladium-catalyzed enantioselective alkylation chemistry.

[1860-5397-10-261-i14]

Scheme 14: Pandey’s approach to (+)-vincadifformine.

The formal synthesis of (−)-vincadifformine commenced with ruthenium-catalyzed isomerization of the terminal olefin moiety in unprotected piperidinone (+)-47 (made previously in the formal synthesis of (+)-rhazinilam shown in Scheme 11) to produce internal olefin 63 (Scheme 15) [109]. Ozonolysis of the double bond furnished aldehyde 64, which was reduced under Luche conditions to alcohol 65, a compound identical in structure and enantiomeric to the intermediate employed by Pandey in the synthesis of (+)-vincadifformine.

[1860-5397-10-261-i15]

Scheme 15: Formal total synthesis of (−)-vincadifformine.

Conclusion

The development of a series of Pd-catalyzed methods for constructing stereogenic quaternary carbons has provided two generations of building blocks (Scheme 16). The described derivatization enabled the formal total syntheses of an array of classic natural products including sugar derivatives, terpenes, and alkaloids, adding significantly to the growing list of uses for this powerful C–C bond construction. An efficient route to the sesquiterpenoid (−)-thujopsene (10) has been delineated, allowing access to the compound’s natural antipode. Our lab’s novel approach to (−)-quinic acid (21) allowed access to either enantiomer of this important substance. We have also intercepted a key intermediate in Danishefsky’s synthesis of (±)-dysidiolide (29), rendering the former racemic route enantioselective. Additionally, a rapid approach to a compound in Meyers’ formal synthesis of (+)-aspidospermine (36) granted access to the natural product without the use of a chiral auxiliary. Finally, we have demonstrated the application of lactam alkylation products in the catalytic asymmetric syntheses of (+)-rhazinilam (44), (+)-quebrachamine (51), and (−)-vincadifformine (59). The powerful catalytic enantioselective allylic alkylation will undoubtedly enable new synthetic endeavors in the context of both academic and industrial research.

[1860-5397-10-261-i16]

Scheme 16: Two generations of building blocks.

Supporting Information

Supporting information features experimental procedures, characterization data of synthesized compounds, copies of 1H and 13C NMR spectra, and single crystal structure data.

Supporting Information File 1: Experimental data, NMR spectra and X-ray data.
Format: PDF Size: 2.6 MB Download

Acknowledgements

We are grateful to NIH (R01GM080269), Amgen, the Gordon and Betty Moore Foundation, and Caltech for funding. We also thank the Caltech Minorities Undergraduate Research Fellowship program, PREM program, Eli Lilly, the Resnick Sustainability Institute at Caltech (fellowship for Y. L.), and the Swiss National Science Foundation (SNSF, fellowship for M. L.). Dr. Michael L. Krout and Dr. David E. White are acknowledged for preliminary experimental work related to their results. Dr. Michael Takase (Caltech) and Larry Henling (Caltech) are gratefully acknowledged for X-ray crystallographic structural determination.

References

  1. Trost, B. M.; Jiang, C. Synthesis 2006, 369–396. doi:10.1055/s-2006-926302
    Return to citation in text: [1]
  2. Mohr, J. T.; Stoltz, B. M. Chem. – Asian J. 2007, 2, 1476–1491. doi:10.1002/asia.200700183
    Return to citation in text: [1]
  3. Behenna, D. C.; Mohr, J. T.; Sherden, N. H.; Marinescu, S. C.; Harned, A. M.; Tani, K.; Seto, M.; Ma, S.; Novák, Z.; Krout, M. R.; McFadden, R. M.; Roizen, J. L.; Enquist, J. A., Jr.; White, D. E.; Levine, S. R.; Petrova, K. V.; Iwashita, A.; Virgil, S. C.; Stoltz, B. M. Chem. – Eur. J. 2011, 17, 14199–14223. doi:10.1002/chem.201003383
    Return to citation in text: [1]
  4. McFadden, R. M.; Stoltz, B. M. J. Am. Chem. Soc. 2006, 128, 7738–7739. doi:10.1021/ja061853f
    Return to citation in text: [1]
  5. White, D. E.; Stewart, I. C.; Grubbs, R. H.; Stoltz, B. M. J. Am. Chem. Soc. 2008, 130, 810–811. doi:10.1021/ja710294k
    Return to citation in text: [1]
  6. Enquist, J. A., Jr.; Stoltz, B. M. Nature 2008, 453, 1228–1231. doi:10.1038/nature07046
    Return to citation in text: [1]
  7. Enquist, J. A., Jr.; Virgil, S. C.; Stoltz, B. M. Chem. – Eur. J. 2011, 17, 9957–9969. doi:10.1002/chem.201100425
    Return to citation in text: [1]
  8. Enquist, J. A., Jr.; Stoltz, B. M. Nat. Prod. Rep. 2009, 26, 661–680. doi:10.1039/B811227B
    Return to citation in text: [1]
  9. Levine, S. R.; Krout, M. R.; Stoltz, B. M. Org. Lett. 2009, 11, 289–292. doi:10.1021/ol802409h
    Return to citation in text: [1]
  10. Petrova, K. V.; Mohr, J. T.; Stoltz, B. M. Org. Lett. 2009, 11, 293–295. doi:10.1021/ol802410t
    Return to citation in text: [1]
  11. White, D. E.; Stewart, I. C.; Seashore-Ludlow, B. A.; Grubbs, R. H.; Stoltz, B. M. Tetrahedron 2010, 66, 4668–4686. doi:10.1016/j.tet.2010.04.128
    Return to citation in text: [1]
  12. Day, J. J.; McFadden, R. M.; Virgil, S. C.; Kolding, H.; Alleva, J. L.; Stoltz, B. M. Angew. Chem., Int. Ed. 2011, 50, 6814–6818. doi:10.1002/anie.201101842
    Return to citation in text: [1]
  13. Wei, Y.; Zhao, D.; Ma, D. Angew. Chem., Int. Ed. 2013, 52, 12988–12991. doi:10.1002/anie.201307788
    Return to citation in text: [1]
  14. Xu, Z.; Wang, Q.; Zhu, J. J. Am. Chem. Soc. 2013, 135, 19127–19130. doi:10.1021/ja4115192
    Return to citation in text: [1]
  15. Hu, Q.-Y.; Zhou, G.; Corey, E. J. J. Am. Chem. Soc. 2004, 126, 13708–13713. doi:10.1021/ja046154m
    Return to citation in text: [1]
  16. Ko, S. Y.; Lee, A. W. M.; Masamune, S.; Reed, L. A., III; Sharpless, K. B.; Walker, F. J. Science 1983, 220, 949–951. doi:10.1126/science.220.4600.949
    Return to citation in text: [1]
  17. Inamori, Y.; Morita, Y.; Sakagami, Y.; Okabe, T.; Ishida, N. Biocontrol Sci. 2006, 11, 49–54. doi:10.4265/bio.11.49
    Return to citation in text: [1]
  18. Chetty, G. L.; Dev, S. Tetrahedron Lett. 1965, 6, 3773–3776. doi:10.1016/S0040-4039(01)99562-0
    Return to citation in text: [1]
  19. Itô, S.; Endo, K.; Honma, H.; Ota, K. Tetrahedron Lett. 1965, 6, 3777–3781. doi:10.1016/S0040-4039(01)99563-2
    Return to citation in text: [1]
  20. Oh, I.; Yang, W.-Y.; Park, J.; Lee, S.; Mar, W.; Oh, K.-B.; Shin, J. Arch. Pharmacal Res. 2011, 34, 2141–2147. doi:10.1007/s12272-011-1218-5
    Return to citation in text: [1]
  21. Yano, M. J. Soc. Chem. Ind., Jpn. 1913, 16, 443–463.
    Return to citation in text: [1]
  22. Uchida, S. J. Soc. Chem. Ind., Jpn. 1928, 31, 501–503.
    Return to citation in text: [1]
  23. Miyazaki, Y. Mokuzai Gakkaishi 1996, 42, 624–626.
    Return to citation in text: [1]
  24. Hiramatsu, Y.; Miyazaki, Y. J. Wood Sci. 2001, 47, 13–17. doi:10.1007/BF00776639
    Return to citation in text: [1]
  25. Dauben, W. G.; Ashcraft, A. C. J. Am. Chem. Soc. 1963, 85, 3673–3676. doi:10.1021/ja00905a032
    Return to citation in text: [1]
  26. Büchi, G.; White, J. D. J. Am. Chem. Soc. 1964, 86, 2884–2887. doi:10.1021/ja01068a024
    Return to citation in text: [1]
  27. Mori, K.; Ohki, M.; Kobayashi, A.; Matsui, M. Tetrahedron 1970, 26, 2815–2819. doi:10.1016/S0040-4020(01)92857-1
    Return to citation in text: [1]
  28. McMurry, J. E.; Blaszczak, L. C. J. Org. Chem. 1974, 39, 2217–2222. doi:10.1021/jo00929a017
    Return to citation in text: [1]
  29. Branca, S. J.; Lock, R. L.; Smith, A. B., III. J. Org. Chem. 1977, 42, 3165–3168. doi:10.1021/jo00439a012
    Return to citation in text: [1]
  30. Johnson, C. R.; Barbachyn, M. R. J. Am. Chem. Soc. 1982, 104, 4290–4291. doi:10.1021/ja00379a060
    Return to citation in text: [1]
  31. Lee, E.; Shin, I.-J.; Kim, T.-S. J. Am. Chem. Soc. 1990, 112, 260–264. doi:10.1021/ja00157a041
    Return to citation in text: [1]
  32. Zhang, C. X.; Fang, L. J.; Bi, F. Q.; Li, Y. L. Chin. Chem. Lett. 2008, 19, 256–258. doi:10.1016/j.cclet.2008.01.009
    Return to citation in text: [1]
  33. Srikrishna, A.; Anebouselvy, K. J. Org. Chem. 2001, 66, 7102–7106. doi:10.1021/jo0105484
    Return to citation in text: [1]
  34. Behenna, D. C.; Stoltz, B. M. J. Am. Chem. Soc. 2004, 126, 15044–15045. doi:10.1021/ja044812x
    Return to citation in text: [1] [2] [3] [4]
  35. Rapado, L. P.; Bulugahapitiya, V.; Renaud, P. Helv. Chim. Acta 2000, 83, 1625–1632. doi:10.1002/1522-2675(20000705)83:7<1625::AID-HLCA1625>3.0.CO;2-W
    Return to citation in text: [1] [2]
  36. Wolinsky, J.; Novak, R.; Vasilev, R. J. Org. Chem. 1964, 29, 3596–3598. doi:10.1021/jo01035a038
    Return to citation in text: [1] [2]
  37. Barco, A.; Benetti, S.; De Risi, C.; Marchetti, P.; Pollini, G. P.; Zanirato, V. Tetrahedron: Asymmetry 1997, 8, 3515–3545. doi:10.1016/S0957-4166(97)00471-0
    Return to citation in text: [1]
  38. Garg, N. K.; Caspi, D. D.; Stoltz, B. M. J. Am. Chem. Soc. 2004, 126, 9552–9553. doi:10.1021/ja046695b
    Return to citation in text: [1]
  39. Garg, N. K.; Caspi, D. D.; Stoltz, B. M. J. Am. Chem. Soc. 2005, 127, 5970–5978. doi:10.1021/ja050586v
    Return to citation in text: [1]
  40. Garg, N. K.; Stoltz, B. M. Chem. Commun. 2006, 3769–3779. doi:10.1039/B605929E
    Return to citation in text: [1]
  41. Garg, N. K.; Caspi, D. D.; Stoltz, B. M. Synlett 2006, 3081–3087. doi:10.1055/s-2006-951492
    Return to citation in text: [1]
  42. Rohloff, J. C.; Kent, K. M.; Postich, M. J.; Becker, M. W.; Chapman, H. H.; Kelly, D. E.; Lew, W.; Louie, M. S.; McGee, L. R.; Prisbe, E. J.; Schultze, L. M.; Yu, R. H.; Zhang, L. J. Org. Chem. 1998, 63, 4545–4550. doi:10.1021/jo980330q
    Return to citation in text: [1]
  43. Seto, M.; Roizen, J. L.; Stoltz, B. M. Angew. Chem., Int. Ed. 2008, 47, 6873–6876. doi:10.1002/anie.200801424
    Return to citation in text: [1] [2] [3] [4] [5]
  44. Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Org. Lett. 1999, 1, 953–956. doi:10.1021/ol990909q
    Return to citation in text: [1]
  45. Gunasekera, S. P.; McCarthy, P. J.; Kelly-Borges, M. J. Am. Chem. Soc. 1996, 118, 8759–8760. doi:10.1021/ja961961+
    Return to citation in text: [1] [2] [3]
  46. Millar, J. B. A.; Russel, P. Cell 1992, 68, 407–410. doi:10.1016/0092-8674(92)90177-E
    Return to citation in text: [1]
  47. Boukouvalas, J.; Cheng, Y.-X.; Robichaud, J. J. Org. Chem. 1998, 63, 228–229. doi:10.1021/jo972208h
    Return to citation in text: [1]
  48. Magnuson, S. R.; Sepp-Lorenzino, L.; Rosen, N.; Danishefsky, S. J. J. Am. Chem. Soc. 1998, 120, 1615–1616. doi:10.1021/ja9740428
    Return to citation in text: [1] [2]
  49. Miyaoka, H.; Kajiwara, Y.; Yamada, Y. Tetrahedron Lett. 2000, 41, 911–914. doi:10.1016/S0040-4039(99)02175-9
    Return to citation in text: [1]
  50. Takahashi, M.; Dodo, K.; Hashimoto, Y.; Shirai, R. Tetrahedron Lett. 2000, 41, 2111–2114. doi:10.1016/S0040-4039(00)00078-2
    Return to citation in text: [1]
  51. Paczkowski, R.; Maichle-Mössmer, C.; Maier, M. E. Org. Lett. 2000, 2, 3967–3969. doi:10.1021/ol006742e
    Return to citation in text: [1]
  52. Miyaoka, H.; Yamada, Y. Bull. Chem. Soc. Jpn. 2002, 75, 203–222. doi:10.1246/bcsj.75.203
    Return to citation in text: [1]
  53. Demeke, D.; Forsyth, C. J. Tetrahedron 2002, 58, 6531–6544. doi:10.1016/S0040-4020(02)00663-4
    Return to citation in text: [1]
  54. Corey, E. J.; Roberts, B. E. J. Am. Chem. Soc. 1997, 119, 12425–12431. doi:10.1021/ja973023v
    Return to citation in text: [1]
  55. Miyaoka, H.; Kajiwara, Y.; Hara, Y.; Yamada, Y. J. Org. Chem. 2001, 66, 1429–1435. doi:10.1021/jo0015772
    Return to citation in text: [1]
  56. Jung, M. E.; Nishimura, N. Org. Lett. 2001, 3, 2113–2115. doi:10.1021/ol016073k
    Return to citation in text: [1]
  57. Das, P. P.; Lysenko, I. L.; Cha, J. K. Angew. Chem., Int. Ed. 2011, 50, 9459–9461. doi:10.1002/anie.201104331
    Return to citation in text: [1]
  58. Mohr, J. T.; Behenna, D. C.; Harned, A. M.; Stoltz, B. M. Angew. Chem., Int. Ed. 2005, 44, 6924–6927. doi:10.1002/anie.200502018
    Return to citation in text: [1]
  59. Mohr, J. T.; Krout, M. R.; Stoltz, B. M. Org. Synth. 2009, 86, 194–211.
    Return to citation in text: [1]
  60. Saxton, J. E. Alkaloids of the Aspidospermine Group. In The Alkaloids; Cordell, G. A., Ed.; Academic Press: San Diego, 1998; Vol. 51, pp 2–198.
    Return to citation in text: [1] [2]
  61. Stork, G.; Dolfini, J. E. J. Am. Chem. Soc. 1963, 85, 2872–2873. doi:10.1021/ja00901a061
    Return to citation in text: [1] [2]
  62. Ban, Y.; Sato, Y.; Inoue, I.; Nagai, M.; Oishi, T.; Terashima, M.; Yonematsu, O.; Kanaoka, Y. Tetrahedron Lett. 1965, 6, 2261–2268. doi:10.1016/S0040-4039(00)70368-6
    Return to citation in text: [1]
  63. Meyers, A. I.; Berney, D. J. Org. Chem. 1989, 54, 4673–4676. doi:10.1021/jo00280a040
    Return to citation in text: [1]
  64. Lawton, G.; Saxton, J. E.; Smith, A. J. Tetrahedron 1977, 33, 1641–1653. doi:10.1016/0040-4020(77)80177-4
    Return to citation in text: [1]
  65. Spessard, S. J.; Stoltz, B. M. Org. Lett. 2002, 4, 1943–1946. doi:10.1021/ol025968+
    Return to citation in text: [1]
  66. Stork, G.; Danheiser, R. L. J. Org. Chem. 1973, 38, 1775–1776. doi:10.1021/jo00949a048
    Return to citation in text: [1]
  67. Bennett, N. B.; Hong, A. Y.; Harned, A. M.; Stoltz, B. M. Org. Biomol. Chem. 2012, 10, 56–59. doi:10.1039/C1OB06189E
    Return to citation in text: [1]
  68. Banerji, A.; Majumder, P. L.; Chatterjee, A. G. Phytochemistry 1970, 9, 1491–1493. doi:10.1016/S0031-9422(00)85265-6
    Return to citation in text: [1]
  69. Linde, H. H. A. Helv. Chim. Acta 1965, 48, 1822–1842. doi:10.1002/hlca.19650480803
    Return to citation in text: [1]
  70. Thoison, O.; Guénard, D.; Sévenet, T.; Kan-Fan, C.; Quirion, J.-C.; Husson, H. P.; Deverre, J.-R.; Chan, K. C.; Potier, P. C. R. Acad. Sci. Paris II 1987, 304, 157–160.
    Return to citation in text: [1]
  71. Abraham, D. J.; Rosenstein, R. D.; Lyon, R. L.; Fong, H. H. S. Tetrahedron Lett. 1972, 13, 909–912. doi:10.1016/S0040-4039(01)84471-3
    Return to citation in text: [1]
  72. Alazard, J.-P.; Millet-Paillusson, C.; Boyé, O.; Guénard, D.; Chiaroni, A.; Riche, C.; Thal, C. Bioorg. Med. Chem. Lett. 1991, 1, 725–728. doi:10.1016/S0960-894X(01)81056-8
    Return to citation in text: [1]
  73. Edler, M. C.; Yang, G.; Jung, M. K.; Bai, R.; Bornmann, W. G.; Hamel, E. Arch. Biochem. Biophys. 2009, 487, 98–104. doi:10.1016/j.abb.2009.05.014
    Return to citation in text: [1]
  74. Kholod, I.; Vallat, O.; Buciumas, A.-M.; Neier, R. Heterocycles 2011, 82, 917–948. doi:10.3987/REV-10-SR(E)2
    See for a review.
    Return to citation in text: [1]
  75. Ratcliffe, A. H.; Smith, G. F.; Smith, G. N. Tetrahedron Lett. 1973, 14, 5179–5184. doi:10.1016/S0040-4039(01)87657-7
    Return to citation in text: [1]
  76. Johnson, J. A.; Sames, D. J. Am. Chem. Soc. 2000, 122, 6321–6322. doi:10.1021/ja0003223
    Return to citation in text: [1]
  77. Bowie, A. L., Jr.; Hughes, C. C.; Trauner, D. Org. Lett. 2005, 7, 5207–5209. doi:10.1021/ol052033v
    Return to citation in text: [1]
  78. Johnson, J. A.; Li, N.; Sames, D. J. Am. Chem. Soc. 2002, 124, 6900–6903. doi:10.1021/ja026130k
    Return to citation in text: [1]
  79. Banwell, M. G.; Beck, D. A. S.; Willis, A. C. ARKIVOC 2006, No. 3, 163–174.
    Return to citation in text: [1]
  80. Liu, Z.; Wasmuth, A. S.; Nelson, S. G. J. Am. Chem. Soc. 2006, 128, 10352–10353. doi:10.1021/ja0629110
    Return to citation in text: [1]
  81. Gu, Z.; Zakarian, A. Org. Lett. 2010, 12, 4224–4227. doi:10.1021/ol101523z
    Return to citation in text: [1]
  82. Sugimoto, K.; Toyoshima, K.; Nonaka, S.; Kotaki, K.; Ueda, H.; Tokuyama, H. Angew. Chem., Int. Ed. 2013, 52, 7168–7171. doi:10.1002/anie.201303067
    Return to citation in text: [1]
  83. Magnus, P.; Rainey, T. Tetrahedron 2001, 57, 8647–8651. doi:10.1016/S0040-4020(01)00859-6
    Return to citation in text: [1]
  84. Behenna, D. C.; Liu, Y.; Yurino, T.; Kim, J.; White, D. E.; Virgil, S. C.; Stoltz, B. M. Nat. Chem. 2012, 4, 130–133. doi:10.1038/nchem.1222
    Return to citation in text: [1] [2] [3] [4] [5]
  85. Deutsch, H. F.; Evenson, M. A.; Drescher, P.; Sparwasser, C.; Madsen, P. O. J. Pharm. Biomed. Anal. 1994, 12, 1283–1287. doi:10.1016/0731-7085(94)00066-2
    Return to citation in text: [1]
  86. Coldham, I.; Burrell, A. J. M.; White, L. E.; Adams, H.; Oram, N. Angew. Chem., Int. Ed. 2007, 46, 6159–6162. doi:10.1002/anie.200701943
    Return to citation in text: [1]
  87. Bajtos, B.; Pagenkopf, B. L. Eur. J. Org. Chem. 2009, 1072–1077. doi:10.1002/ejoc.200801154
    Return to citation in text: [1]
  88. Hsu, S.-W.; Cheng, H.-Y.; Huang, A.-C.; Ho, T.-L.; Hou, D.-R. Eur. J. Org. Chem. 2014, 3109–3115. doi:10.1002/ejoc.201400064
    Return to citation in text: [1]
  89. Temme, O.; Taj, S.-A.; Andersson, P. G. J. Org. Chem. 1998, 63, 6007–6015. doi:10.1021/jo9807417
    Return to citation in text: [1]
  90. Kozmin, S. A.; Iwama, T.; Huang, Y.; Rawal, V. H. J. Am. Chem. Soc. 2002, 124, 4628–4641. doi:10.1021/ja017863s
    Return to citation in text: [1]
  91. Sattely, E. S.; Meek, S. J.; Malcolmson, S. J.; Schrock, R. R.; Hoveyda, A. H. J. Am. Chem. Soc. 2009, 131, 943–953. doi:10.1021/ja8084934
    Return to citation in text: [1]
  92. Amat, M.; Lozano, O.; Escolano, C.; Molins, E.; Bosch, J. J. Org. Chem. 2007, 72, 4431–4439. doi:10.1021/jo070397q
    Return to citation in text: [1]
  93. Smith, G. F.; Wahid, M. A. J. Chem. Soc. 1963, 4002–4004. doi:10.1039/JR9630004002
    Return to citation in text: [1]
  94. Szántay, C. Pure Appl. Chem. 1990, 62, 1299–1302. doi:10.1351/pac199062071299
    Return to citation in text: [1]
  95. Danieli, B.; Lesma, G.; Palmisano, G.; Gabetta, B. J. Chem. Soc., Chem. Commun. 1981, 908–909. doi:10.1039/C39810000908
    Return to citation in text: [1]
  96. Sápi, J.; Szabó, L.; Baitz-Gács, E.; Kalaus, G.; Szántay, C. Tetrahedron 1988, 44, 4619–4629. doi:10.1016/S0040-4020(01)86164-0
    Return to citation in text: [1]
  97. Calabi, L.; Danieli, B.; Lesma, G.; Palmisano, G. J. Chem. Soc., Perkin Trans. 1 1982, 1371–1379. doi:10.1039/P19820001371
    Return to citation in text: [1]
  98. Kutney, J. P.; Chan, K. K.; Failli, A.; Fromson, J. M.; Gletsos, C.; Nelson, V. R. J. Am. Chem. Soc. 1968, 90, 3891–3893. doi:10.1021/ja01016a069
    Return to citation in text: [1]
  99. Laronze, P. J.-Y.; Laronze-Fontaine, J.; Lévy, J.; Le Men, J. Tetrahedron Lett. 1974, 15, 491–494. doi:10.1016/S0040-4039(01)82252-8
    Return to citation in text: [1]
  100. Kuehne, M. E.; Roland, D. M.; Hafter, R. J. Org. Chem. 1978, 43, 3705–3710. doi:10.1021/jo00413a015
    Return to citation in text: [1]
  101. Barsi, M.-C.; Das, B. C.; Fourrey, J.-L.; Sundaramoorthi, R. J. Chem. Soc., Chem. Commun. 1985, 88–89. doi:10.1039/C39850000088
    Return to citation in text: [1]
  102. Yoshida, K.; Nomura, S.; Ban, Y. Tetrahedron 1985, 41, 5495–5501. doi:10.1016/S0040-4020(01)91349-3
    Return to citation in text: [1]
  103. Kalaus, G.; Greiner, I.; Kajtár-Peredy, M.; Brlik, J.; Szabó, L.; Szántay, C. J. Org. Chem. 1993, 58, 1434–1442. doi:10.1021/jo00058a025
    Return to citation in text: [1]
  104. Kobayashi, S.; Peng, G.; Fukuyama, T. Tetrahedron Lett. 1999, 40, 1519–1522. doi:10.1016/S0040-4039(98)02667-7
    Return to citation in text: [1]
  105. Kuehne, M. E.; Podhorez, D. E. J. Org. Chem. 1985, 50, 924–929. doi:10.1021/jo00207a002
    Return to citation in text: [1]
  106. Pandey, G.; Kumara, P. C. Org. Lett. 2011, 13, 4672–4675. doi:10.1021/ol201892j
    Return to citation in text: [1] [2]
  107. Jones, S. B.; Simmons, B.; Mastracchio, A.; MacMillan, D. W. C. Nature 2011, 475, 183–188. doi:10.1038/nature10232
    Return to citation in text: [1]
  108. Zhao, S.; Andrade, R. B. J. Am. Chem. Soc. 2013, 135, 13334–13337. doi:10.1021/ja408114u
    Return to citation in text: [1]
  109. Arisawa, M.; Terada, Y.; Nakagawa, M.; Nishida, A. Angew. Chem., Int. Ed. 2002, 41, 4732–4734. doi:10.1002/anie.200290031
    Return to citation in text: [1]

© 2014 Liu et al; licensee Beilstein-Institut.
This is an Open Access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The license is subject to the Beilstein Journal of Organic Chemistry terms and conditions: (http://www.beilstein-journals.org/bjoc)

Other Beilstein-Institut Open Science Activities
Journal Logo
Institut Logo
Preprint Logo
Symposia Logo